108 related articles for article (PubMed ID: 3334107)
1. A multicenter study of the safety and efficacy of naproxen: analysis of blood pressure.
Goldberg MA
Semin Arthritis Rheum; 1988 Feb; 17(3 Suppl 2):23-8. PubMed ID: 3334107
[TBL] [Abstract][Full Text] [Related]
2. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
[TBL] [Abstract][Full Text] [Related]
4. Effects of naproxcinod on blood pressure in patients with osteoarthritis.
White WB; Schnitzer TJ; Bakris GL; Frayssinet H; Duquesroix B; Weber M
Am J Cardiol; 2011 May; 107(9):1338-45. PubMed ID: 21371681
[TBL] [Abstract][Full Text] [Related]
5. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group.
Caldwell JR; Roth SH
J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
Kivitz AJ; Moskowitz RW; Woods E; Hubbard RC; Verburg KM; Lefkowith JB; Geis GS
J Int Med Res; 2001; 29(6):467-79. PubMed ID: 11803730
[TBL] [Abstract][Full Text] [Related]
7. Assessment of blood pressure during naproxen therapy in hypertensive patients treated with nicardipine.
Klassen DK; Jane LH; Young DY; Peterson CA
Am J Hypertens; 1995 Feb; 8(2):146-53. PubMed ID: 7755942
[TBL] [Abstract][Full Text] [Related]
8. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis.
White WB; Schnitzer TJ; Fleming R; Duquesroix B; Beekman M
Am J Cardiol; 2009 Sep; 104(6):840-5. PubMed ID: 19733721
[TBL] [Abstract][Full Text] [Related]
9. Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients.
Gualtierotti R; Zoppi A; Mugellini A; Derosa G; D'Angelo A; Fogari R
Expert Opin Pharmacother; 2013 Oct; 14(14):1875-84. PubMed ID: 23883161
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
Lisse JR; Perlman M; Johansson G; Shoemaker JR; Schechtman J; Skalky CS; Dixon ME; Polis AB; Mollen AJ; Geba GP;
Ann Intern Med; 2003 Oct; 139(7):539-46. PubMed ID: 14530224
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety of naproxen and esomeprazole magnesium fixed-dose combination: phase III study in patients at risk for NSAID-associated gastric ulcers.
Sostek MB; Fort JG; Estborn L; Vikman K
Curr Med Res Opin; 2011 Apr; 27(4):847-54. PubMed ID: 21319944
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: a randomized, double-blind, parallel-group, multicenter study.
Baerwald C; Verdecchia P; Duquesroix B; Frayssinet H; Ferreira T
Arthritis Rheum; 2010 Dec; 62(12):3635-44. PubMed ID: 20722026
[TBL] [Abstract][Full Text] [Related]
13. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study.
Dore R; Ballard I; Constantine G; McDonald P
Clin Ther; 1995; 17(4):656-66. PubMed ID: 8565029
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multicenter trial of nimesulide-beta-cyclodextrin versus naproxen in patients with osteoarthritis.
Fioravanti A; Storri L; Di Martino S; Bisogno S; Oldani V; Scotti A; Marcolongo R
Clin Ther; 2002 Apr; 24(4):504-19. PubMed ID: 12017396
[TBL] [Abstract][Full Text] [Related]
16. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
Altman RD; Moskowitz R
J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
[TBL] [Abstract][Full Text] [Related]
17. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
Fleischmann RM; Flint K; Constantine G; Kolecki B
Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
Reginster JY; Malmstrom K; Mehta A; Bergman G; Ko AT; Curtis SP; Reicin AS
Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
[TBL] [Abstract][Full Text] [Related]
19. Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients.
Schuna AA; Vejraska BD; Hiatt JG; Kochar M; Day R; Goodfriend TL
J Clin Pharmacol; 1989 Jun; 29(6):524-8. PubMed ID: 2666452
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
